secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRUKER CORP (BRKR)
CIK:        0001109354
Form:       8-K
Filed at:   2025-12-09T23:59:59+00:00
Accession:  0001193125-25-312106
Event type: leadership
Sentiment:  positive
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bruker appoints diagnostics industry veteran Jack Phillips to board, effective Jan 2026
--------------------------------------------------------------------------------

- Jack Phillips appointed to Bruker board effective Jan 1, 2026, filling newly created 11th director seat.
- Phillips previously President & CEO of Accelerate Diagnostics (2020-25) and Roche Diagnostics North America (2010-20).
- CEO Laukien says addition is timely as Bruker broadens infectious disease diagnostics portfolio.
- Phillips will serve until 2027 Annual Meeting; compensation consistent with other non-employee directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1109354/000119312525312106/0001193125-25-312106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1109354/000119312525312106/brkr-20251209.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-312106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer